Cellular, Molecular and Non-Pharmacological Therapeutic Advances for the Treatment of Parkinson's Disease: Separating Hope from Hype

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|18|4|206-224

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.18, Iss.4, 2018-08, pp. : 206-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Depression in Parkinson's Disease: Pharmacological Characteristics and Treatment

By Tom T.  

Drugs & Aging, Vol. 12, Iss. 1, 1998-01 ,pp. : 55-74

Adis International

Access to resources Recommend Favorite

Emerging Therapies in the Pharmacological Treatment of Parkinson’s Disease

By Korczyn A.D.   Nussbaum M.  

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 775-786

Adis International

Access to resources Recommend Favorite

Recent developments in the pharmacological treatment of Parkinson’s disease

By Tuite Paul   Riss Jennifer  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1335-1352

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Prolyl Hydroxylase Domain Inhibition as a Therapeutic Target for Parkinson’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 1, 2014-02 ,pp. : 120-125

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression

By  

Current Pharmaceutical Design, Vol. 12, Iss. 4, 2006-02 ,pp. : 503-515

Bentham Science Publishers

Access to resources Recommend Favorite